Related Experiment Videos
Plasma concentrations of benzodiazepines
British Journal of Clinical Pharmacology
|February 1, 1977
Summary
This study found no direct link between benzodiazepine drug levels and patient anxiety symptom improvement. However, medazepam levels showed some correlation with physiological effects in anxious patients.
Area of Science:
- Pharmacology
- Clinical Psychology
- Neuroscience
Background:
- Anxiety disorders are prevalent, often treated with benzodiazepines.
- Understanding the relationship between drug concentration and clinical outcomes is crucial for effective treatment.
Purpose of the Study:
- To investigate the efficacy of various benzodiazepines in treating anxiety.
- To explore the correlation between plasma drug concentrations and clinical/physiological effects.
Main Methods:
- Twenty anxious patients received medazepam, diazepam, chlordiazepoxide, amylobarbitone, or placebo for 2-4 weeks.
- Clinical, physiological, and behavioral variables were assessed, alongside plasma drug and metabolite levels.
Main Results:
- Nordiazepam was identified as a key metabolite for medazepam and diazepam.
- No significant correlation was observed between plasma drug concentrations and clinical or behavioral measures.
- Medazepam levels showed a relationship with observed physiological effects.
Conclusions:
- Plasma concentrations of tested benzodiazepines did not correlate with anxiety symptom improvement.
- Further research is needed to elucidate the complex relationship between benzodiazepine pharmacokinetics and therapeutic effects.